News

The Doctor Founder Taking On Microsoft: Shiv Rao on Building Healthcare's $5.3B AI Operating System

Key takeaways from the Upstarts Media podcast interview with Abridge founder and CEO Shiv RaoDealroom has a profile for this one. Try Dealroom → (July 2026):

The problem. US healthcare spends $1.5 trillion annually on administrative costs. Doctors are burned out, patients don't understand the advice they're given, and a practicing cardiologist saw both sides — as a doctor and as a patient navigating fertility treatments with his spouse. "We'd look at each other and be like, 'What did they just say?' And I'm a doctor," Rao says.

Not a scribe — an operating system. Founded in Pittsburgh in 2018, Abridge automates the clerical work of a clinical visit — notes, billing, and increasingly clinical decision support. Rao frames it as the "AI operating system" for healthcare, not a documentation tool. Valued at $5.3 billion, the platform serves 300+ health systems and reaches 250 million Americans.

Before ChatGPT. Abridge started three months after the "Attention Is All You Need" paper, fine-tuning BERT, Longformer, Pegasus and T5 — years before large language models went mainstream. Rao's early bet on AI-native healthcare infrastructure gave Abridge a head start that competitors including Microsoft's Nuance are still chasing.

Eating glass and kissing frogs. Rao describes years of grinding through enterprise healthcare sales — top-down deployments requiring security and compliance clearances with CIOs before Abridge could ingest EMR data. Healthcare "moves at the speed of trust," and reaching scale meant years of painful enterprise cycles before the product could prove itself.

The YOLO move against Microsoft. Rao's "Upstart Moment" was deciding to take on Microsoft head-to-head. With Nuance as the entrenched incumbent in medical transcription, Abridge positioned itself as something different — not an EMR, not a scribe, but an intelligence layer built on the clinical conversation itself. Doctors now use "abridge" as a verb.

Strategic partners, not rivals. Abridge builds on top of EpicDealroom has a profile for this one. Try Dealroom → rather than against it ("We don't want to be an EMR"), and has partnered with NVIDIA on a foundation model for clinical conversations, Eli Lilly for clinical trial screening, and works with Anthropic and OpenAI on frontier model integration.

Why IBM Watson failed where Abridge didn't. Watson over-promised and eroded trust in healthcare AI. Rao insists on shipping real product — "not slides" — to an industry where 1 in 5 Americans works in healthcare. Abridge's 450-person team operates with a wartime posture: Rao travels five days a week and is exploring a flatter org with fewer managers and more high-judgment individual contributors.

Read more: Upstarts Media podcast

More top stories